global pandemic
Bangladesh raises concern over UK's travel 'red list'
Bangladesh High Commissioner to the UK Saida Muna Tasneem has briefed the Uk's all-party parliamentary group (APPG) about the inconveniences caused by the country's travel ban that has put Bangladesh among the nations on its "red list."
She said the decision would seriously hurt the bilateral trade in the apparel, food and beverage sectors and also emergency medical treatments.
On April 2, the UK said it would put Bangladesh, Kenya, Pakistan and the Philippines on its travel "red list," banning entry to people arriving from those countries unless they are Britons or Irish.
The high commissioner, during a recent virtual meeting with the APPG on Bangladesh, raised two issues including the UK's travel "red list," and the protracted Rohingya crisis.
Also read: Covid-19 in Bangladesh: 95 more die with infection rate falling to 15.07pc
Praising the British government's role on the Rohingya issue especially as the pen-holder at the UN Security Council, she called upon the APPG to keep the issue of the sustainable and dignified return of the Rohingyas back to Myanmar high on its agenda at the British Parliament.
She took great pride in the extraordinary achievements and contributions made by the enterprising expatriate Bangladeshis in the UK in enhancing the shared prosperity of both countries.
"The government of Prime Minister Sheikh Hasina looks forward to further intensifying Bangladesh's bilateral trade, investment, climate and digital innovation partnership with a post-Brexit 'Global Britain," Muna said.
Also read: 14-day institutional quarantine mandatory for travellers from European countries: CAAB
The virtual meeting was held to mark the 50th anniversary of Bangladesh's independence.
Chaired by Rushanara Ali, MP, chairman of the APPG on Bangladesh and UK's trade envoy to Bangladesh, the meeting was also attended by the vice-chairs of the parliamentary group including Bob Blackman MP, Rupa Huq MP, Afzal Khan MP, Khalid Mahmood MP, Tony Llyod MP, and Geraint Davies MP.
Rushanara said, "As a British-Bangladeshi, I am extremely proud to mark the 50th anniversary of Bangladesh's independence. I pay tribute to all those who sacrificed their lives for our freedom and independence. We are forever indebted to them."
Also read: Fully vaccinated people can travel safely again, CDC says
APPG vice-chairs Bob Blackman, MP, and Geraint Davies, MP, praised Bangladesh for its sustained growth and progress over the past 50 years.
Other members of the APPG including Khalid Mahmood, MP, praised Bangladesh's climate leadership.
‘No place for you’: Indian hospitals buckle amid virus surge
Seema Gandotra, sick with the coronavirus, gasped for breath in an ambulance for 10 hours, as it tried unsuccessfully at six hospitals in India’s sprawling capital to find an open bed. By the time she was admitted, it was too late, and the 51-year-old died hours later.
Rajiv Tiwari, whose oxygen levels began falling after he tested positive for the virus, has the opposite problem: He identified an open bed, but the 30-something resident of Lucknow in Uttar Pradesh can’t get to it. “There is no ambulance to take me to hospital,” he said.
Such tragedies are familiar from surges in other parts of the world — but were largely unknown in India, which was able to prevent a collapse in its health system last year through a harsh lockdown. But now they are everyday occurrences in the vast country, which is seeing its largest surge of the pandemic so far and watching its chronically underfunded health system crumble.
Tests are delayed. Medical oxygen is scarce. Hospitals are understaffed and overflowing. Intensive care units are full. Nearly all ventilators are in use, and the dead are piling up at crematoriums and graveyards. India recorded over 250,000 new infections and over 1,700 deaths in the past 24 hours alone, and the U.K. announced a travel ban on most visitors from the country this week. Overall, India has reported more than 15 million cases and some 180,000 deaths — and experts say these numbers are likely an undercounts.
India’s wave of cases is contributing to a worldwide rise in infections as many places experience deepening crises, such as Brazil and France, spurred in part by new, more contagious variants, including one first detected in India. More than a year into the pandemic, global deaths have passed 3 million and are climbing again, running at nearly 12,000 per day on average. At the same time, vaccination campaigns have seen setbacks in many places — and India’s surge has only exacerbated that: The country is a major vaccine producer but was forced it to delay deliveries of shots to focus on its domestic demand.
Also read: Indian capital gasps for oxygen
Bhramar Mukherjee, a biostatistician at the University of Michigan who has been tracking India’s pandemic, said India failed to learn from surges elsewhere and take anticipatory measures.
When new infections started dipping in September, authorities thought the worst of the pandemic was over. Health Minister Harsh Vardhan even declared in March that the country had entered the “endgame” — but he was already behind the curve: Average weekly cases in Maharashtra state, home to the financial capital of Mumbai, had tripled in the previous month.
Mukherjee was among those who had urged authorities to take advantage of cases being low earlier in the year to speed up vaccinations. Instead officials dithered in limiting huge gatherings during Hindu festivals and refused to delay ongoing elections in the eastern West Bengal state, where experts fear that large, unmasked crowds at rallies will fuel the spread of the virus.
Now India’s two largest cities have imposed strict lockdowns, the pain of which will fall inordinately on the poor. Many have already left major cities, fearing a repeat of last year, when an abrupt lockdown forced many migrant workers to walk to their home villages or risk starvation.
New Delhi, the capital, is rushing to convert schools into hospitals. Field hospitals in hard-hit cities that had been abandoned are being resuscitated. India is trying to import oxygen and has started to divert oxygen supplies from industry to the health system.
Also read: India's capital to lock down as nation's virus cases top 15M
It remains to be seen whether these frantic efforts will be enough. New Delhi’s government-run Sanjay Gandhi Hospital is increasing its beds for COVID-19 patients from 46 to 160. But R. Meneka, the official coordinating the COVID-19 response at the hospital, said he wasn’t sure if the facility had the capacity to provide oxygen to that many beds.
The government-run hospital at Burari, an industrial hub in the capitals’ outskirts, only had oxygen for two days Monday, and found that most vendors in the city had run out, said Ramesh Verma, who coordinates the COVID-19 response there.
“Every minute, we keep getting hundreds of calls for beds,” he said.
Kamla Devi, a 71-year-old diabetic, was rushed to a hospital in New Delhi when her blood sugar levels fell last week. On returning home, her levels plummeted again but this time, there were no beds. She died before she could be tested for the virus. “If you have corona(virus) or if you don’t, it doesn’t matter. The hospitals have no place for you,” said Dharmendra Kumar, her son.
Laboratories were unprepared for the steep rise in demand for testing that came with the current surge, and everyone was “caught with their pants down,” said A. Velumani, the chairman and managing director of Thyrocare, one of India’s largest private testing labs. He said that the current demand was three times that of last year.
Also read: India records over 260,000 daily COVID-19 cases, tally at 14,788,109
India’s massive vaccination drive is also struggling. Several states have flagged shortages, although the federal government has claimed there are enough stocks.
India said last week that it would allow the use of all COVID-19 shots that had been greenlit by the World Health Organization or regulators in the United States, Europe, Britain or Japan. On Monday, it said that it would soon expand vaccinations to include every adult in the country, an estimated 900 million people. But with vaccine in short global supply, it isn’t clear when Indian vaccine makers will have the capacity to meet these goals. Indian vaccine maker Bharat Biotech said it was scaling up to make 700 million doses each year.
Meanwhile, Shahid Malik, who works at a small supplier of oxygen, said that the demand for medical oxygen had increased by a factor of 10. His phone has been ringing continuously for two days. By Monday, the shop still had oxygen but no cylinders.
He answered each call with the same message: “If you have your own cylinder, come pick up the oxygen. If you don’t, we can’t help you.”
Indian capital gasps for oxygen
Believe it or not, rising Covid-19 cases have left the Indian capital's medical infrastructure on the brink of collapse. Several hospitals in the city are left with just a few hours of oxygen, the Chief Minister of Delhi said on Tuesday, prompting the High Court to slam the federal government for not banning the industrial use of the life-supporting gas immediately.
On Tuesday, India reported as many as 259,170 Covid-19 cases and 1,761 fatalities in the past 24 hours, the highest daily death toll since the pandemic broke out over a year ago. The national capital alone reported over 30,000 new Covid cases and some 250 deaths.
Also read: India's capital to lock down as nation's virus cases top 15M
"Serious oxygen crisis persists in Delhi. I again urge the Centre (federal government) to urgently provide oxygen to Delhi. Some hospitals are left with just a few hours of oxygen," Chief Minister Arvind Kejriwal tweeted, after a number of leading private hospitals claimed that their oxygen supplies will last for a maximum of 8-12 hours.
Local TV channels also beamed footage of hundreds of Delhi residents queuing up in hospitals, begging for beds for their loved ones with Covid-19 positive reports.
Also read: India records over 260,000 daily COVID-19 cases, tally at 14,788,109
Taking cognizance of the media reports and Kejriwal's tweets, the Delhi High Court also came down heavily on the federal government and questioned its decision to implement a ban on the industrial use of oxygen for Covid patients only from April 22. "Economic interests can't override human lives. Else we are heading for a disaster," the court said.
"Out of 130 crore, there are less than two crore official cases. Even if it's five times, that means only 10 crore cases. We should protect the remaining people. At this rate, we might lose one crore people. We should act fast. We are not here to run the government but you have to be sensitive to the situation," a two-judge bench said.
Also read: Covid-19: Global cases near 142 million, deaths top 3 million
UNB had earlier reported that the Covid-19 pandemic has suddenly turned India into a Covid vaccine importer from a mass exporter. And the government has turned to foreign vaccine producers for inoculating the citizens. The Sputnik vaccine from Russia, officials had said, would arrive next month.
Indian Prime Minister Narendra Modi rolled out the world's largest Covid inoculation programme on January 16. Two 'Made in India' jabs, one developed by the Serum Institute in collaboration with AstraZeneca, and the other by Bharat Biotech, are being given.
Stalled at first jab: Vaccine shortages hit poor countries
As many as 60 countries, including some of the world’s poorest, might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help them are blocked until as late as June.
COVAX, the global initiative to provide vaccines to countries lacking the clout to negotiate for scarce supplies on their own, has in the past week shipped more than 25,000 doses to low-income countries only twice on any given day. Deliveries have all but halted since Monday.
During the past two weeks, according to data compiled daily by UNICEF, fewer than 2 million COVAX doses in total were cleared for shipment to 92 countries in the developing world — the same amount injected in Britain alone.
On Friday, the head of the World Health Organization slammed the “shocking imbalance” in global COVID-19 vaccination. WHO Director General Tedros Adhanom Ghebreysus said that while one in four people in rich countries had received a vaccine, only one in 500 people in poorer countries had gotten a dose.
The vaccine shortage stems mostly from India’s decision to stop exporting vaccines from its Serum Institute factory, which produces the overwhelming majority of the AstraZeneca doses that COVAX counted on to supply around a third of the global population at a time coronavirus is spiking worldwide.
Also read: Shocking imbalance in Covid vaccine distribution: WHO
COVAX will only ship vaccines cleared by WHO, and countries are increasingly impatient. Supplies are dwindling in some of the first countries to receive COVAX shipments, and the expected delivery of second doses in the 12-week window currently recommended is now in doubt. In a statement, the vaccine alliance known as GAVI told The Associated Press that 60 countries are affected by the delays.
In vaccination tents set up at Kenyatta National Hospital in Nairobi, many of those who arrived for their first jabs were uneasy about when the second would arrive.
“My fear if I don’t get the second dose, my immune system is going to be weak, hence I might die,” said Oscar Odinga, a civil servant.
Internal WHO documents obtained by the AP show the uncertainty about deliveries “is causing some countries to lose faith in the COVAX (effort).” That is prompting WHO to consider speeding up its endorsement of vaccines from China and Russia, which have not been authorized by any regulators in Europe or North America.
The WHO documents show the U.N. agency is facing questions from COVAX participants about allotments in addition to “uncertainty about whether all those who were vaccinated in round 1 are guaranteed a second dose.”
WHO declined to respond specifically to the issues raised in the internal materials but has previously said countries are “very keen” to get vaccines as soon as possible and insisted it hasn’t heard any complaints about the process.
Also read: Are some Covid-19 vaccines more effective than others?
Concern over the link between the AstraZeneca shot and rare blood clots has also “created nervousness both around its safety and efficacy,” WHO noted. Among its proposed solutions is a decision to “expedite review of additional products” from China and Russia.
WHO said last month it might be possible to greenlight the Chinese vaccines by the end of April.
Some experts have noted that Sinopharm and Sinovac, two Chinese-made vaccines, lack published data, and there are reports of people needing a third dose to be protected.
“If there is something that we miss from not having thoroughly evaluated the risks of serious adverse events from these vaccines, that would undermine the confidence in all the good products that we’re using that we know are safe,” said Dora Curry, director of health equity and rights at CARE International.
Other experts worried that delays could erode faith in governments that were particularly efficient in their vaccination programs and were counting on second doses soon.
“In the absence of high vaccination coverage globally, we risk dragging out the pandemic for several more years,” said Lavanya Vasudevan, an assistant professor at Duke University’s Global Health Institute. “Every day that the virus is in circulation is an opportunity for it to mutate into a more deadly variant.”
Also read: COVAX reaches over 100 economies, 42 days after first international delivery
Earlier this month, the WHO appealed to rich countries to urgently share 10 million doses to meet the U.N. target of starting COVID-19 vaccinations in every country within the first 100 days of the year. So far, countries have pledged hundreds of millions of dollars to COVAX. But there are simply no doses to buy, and no country has agreed to immediately share what it has.
Bilateral donations of doses tend to go along political lines, rather than to countries with the most infections, and they aren’t nearly enough to compensate for the goals that COVAX has set out. Think Global Health, a data site managed by the Council on Foreign Relations, identified 19 countries that have donated a total of 27.5 million doses to 102 nations as of Thursday.
“You can make a strong argument that we’re better off making donations in crisis and getting the pandemic under control than vaccinating low-risk groups at home,” said Thomas Bollyky, director of the Global Health Program at the Council on Foreign Relations. Bollyky said COVAX was both a great disappointment and the only available option for most the world.
According to the International Rescue Committee, COVID-19 cases and deaths last month surged in numerous crisis-hit countries: by 322% in Kenya, 379% in Yemen and 529% in northeast Syria.
On Thursday, the agencies behind COVAX — WHO, vaccines alliance GAVI and CEPI, a coalition for epidemic preparedness — celebrated their delivery of 38 million lifesaving vaccines to more than 100 countries.
Brook Baker, a vaccines expert at Northeastern University, said the laudatory message was misplaced.
Also read: Countries worldwide hit new records for virus cases, deaths
“Celebrating doses sufficient for only 19 million people, or 0.25% of global population, is tone deaf,” he said, adding it was time for WHO and partners to be more honest with countries.
“WHO and GAVI have repeatedly overpromised and underdelivered, so why should we believe that they will suddenly be able to ramp up production and deliveries in a couple of months?” he said.
Outside the vaccination tents in Nairobi on Thursday, Dr. Duncan Nyukuri, an infectious disease physician, tried to reassure people getting their first dose.
“If you receive the first dose and you fail to receive the second dose, this does not mean that your body will be any weaker or you will be at an increased risk of getting any infection,” he said. “What it means is your body will have developed some immunity against the coronavirus infection. But this immunity is not as good as somebody who has received both doses.”
No region in the world spared as virus cases, deaths surge
Hospitals in Turkey and Poland are filling up fast. Pakistan is restricting domestic travel to contain a surge in coronavirus infections. Even Thailand, which has weathered the pandemic far better than many nations, is now struggling to contain a new COVID-19 spike.
The only exceptions to the deteriorating worldwide situation are countries that have advanced vaccination programs, mostly notably Israel and Britain. Even the U.S., which is a vaccination leader globally, is seeing a small uptick in new cases, and the White House announced Friday that it would send federal help to Michigan to control the state’s worst-in-the-nation transmission rate.
The World Health Organization said Friday that it’s concerned about infection rates that are rising in every global region, driven by new virus variants and too many nations coming out of lockdown too soon.
“We’ve seen rises (in cases) worldwide for six weeks. And now, sadly, we are seeing rises in deaths for the last three weeks,” Dr. Margaret Harris, a WHO spokeswoman, said at a briefing in Geneva.
In its latest weekly epidemiological update, the WHO said over 4 million COVID-19 cases were reported in the last week. New deaths increased by 11% compared to last week, with over 71,000 reported.
Also read: Countries worldwide hit new records for virus cases, deaths
The increasing infections, hospitalizations and deaths extend to countries where vaccinations are finally gaining momentum. That leaves even bleaker prospects for much of the world, where large-scale vaccination programs remain a more distant prospect.
In Turkey, which is among the badly hit countries, most new cases of the virus can be traced to a variant first found in Britain.
Ismail Cinel, head of the Turkish Intensive Care Association, said the surge was beginning to strain the nation’s relatively advanced health care system and “the alarm bells are ringing” for intensive care units, which are not yet at full capacity.
“The mutant form of the virus is causing more harm to the organs,” Cinel said. “While 2 out of 10 patients were dying previously, the number is now 4 out of 10. And if we continue this way, we will lose six.”
Turkish President Recep Tayyip Erdogan eased COVID-19 restrictions in early March to minimize pain to his nation’s ailing economy. The new spike forced him to announce renewed restrictions, such as weekend lockdowns and the closure of cafes and restaurants during Ramadan, which starts April 13.
Also read: Global Covid cases top 132 million
Turkish medical groups say the reopening in March was premature and that the new measures do not go far enough. They have been calling for full lockdowns during the holy Muslim month.
In the U.S. capital, President Joe Biden’s administration outlined how the federal government planned to help Michigan better administer the doses already allocated to the state, as well as expand testing capacity and the availability of drugs. The effort will not include any extra vaccine doses, a move Gov. Gretchen Whitmer sought.
Doses are currently allocated to states proportionally by population. Whitmer has called for extra doses to be shifted to states like hers experiencing a sharp rise in cases.
The death toll in Iran is also rising, prompting new restrictions that will take effect for 10 days in 257 cities beginning Saturday. They involve the closure of all parks, restaurants, confectionaries, beauty salons, malls and bookstores.
Authorities in Pakistan, which is in the middle of a third surge of infections, are restricting inter-city transportation on weekends starting at midnight Friday as part of measures aimed at limiting coronavirus cases and deaths.
Also read: COVAX reaches over 100 economies, 42 days after first international delivery
Elsewhere in Asia, authorities in Thailand on Friday ordered new restrictions in an effort to contain a growing coronavirus outbreak just days before the country’s traditional Songkran New Year’s holiday, when millions of people travel.
Japan, meanwhile, announced tougher measures ahead of the Summer Olympics.
In Germany, Poland and other countries in the 27-member European Union, vaccination programs are finally ramping up after a slow start in the first three months of the year due to delivery shortages.
Thousands of German medical practices joined the vaccination campaign this week. That helped Germany reach its second consecutive daily record on Thursday of almost 720,000 doses administered — meaning that 14.7% of the population has now received at least one dose and 5.8% have received both shots.
Yet German health officials are warning of a steep rise in intensive care patients and are calling for stronger action to contain infections.
Also read: Governments give varying advice on AstraZeneca vaccine
Lothar Wieler, the head of Germany’s disease control center, the Robert Koch Institute, said nearly 4,500 COVID-19 patients are receiving intensive care, with the number increasing by 700 over the past week — a 20% rise.
Neighboring Poland is also seeing a dramatic spike in deaths, and hospitals have been forced to turn away cancer and other patients as ICU and other hospital beds are taken by COVID-19 patients. Hospitalizations of virus patients there have jumped 20% in the past two weeks.
Harris, from the WHO, said the world knows how to fight these surges. She cited good news from the U.K., where new coronavirus cases dropped 60% in March amid a strong vaccination program, “but we have to do it all.”
“We have to keep on social distancing. We have to avoid indoor crowded settings. We have to keep wearing the masks, even if vaccinated,” she said. “People are misunderstanding, seeming to think that vaccination will stop transmission. That is not the case. We need to bring down the transmission while giving the vaccination the chance to stop the severe disease.”
Are some Covid-19 vaccines more effective than others?
Do some Covid-19 vaccines work more effectively than others?
It’s hard to tell since they weren’t directly compared in studies. But experts say the vaccines are alike on what matters most: preventing hospitalizations and deaths.
“Luckily, all these vaccines look like they’re protecting us from severe disease,” said Dr Monica Gandhi of the University of California, San Francisco, citing study results for five vaccines used around the world and a sixth that’s still in review.
Also read: Countries worldwide hit new records for virus cases, deaths
And real-world evidence as millions of people receive the vaccines show they’re all working very well.
Still, people might wonder if one is better than another since studies conducted before the vaccines were rolled out found varying levels of effectiveness. The problem is they don’t offer apples-to-apples comparisons.
Consider the two-dose vaccines from Pfizer and Moderna, found to be about 95% effective at preventing illness. Studies for those shots counted a Covid-19 case whether it was mild, moderate or severe — and were conducted before worrisome mutated versions of the virus began circulating.
Also read: Governments give varying advice on AstraZeneca vaccine
Then Johnson & Johnson tested a single-dose vaccine and didn’t count mild illnesses. J&J’s shot was 66% protective against moderate to severe illness in a large international study. In just the U.S., where there’s less spread of variants, it was 72% effective. More importantly, once the vaccine’s effect kicked in it prevented hospitalization and death.
AstraZeneca’s two-dose vaccine used in many countries has faced questions about the exact degree of its effectiveness indicated by studies. But experts agree those shots, too, protect against the worst outcomes.
Also read: COVAX reaches over 100 economies, 42 days after first international delivery
Around the world, hospitalizations are dropping in countries where vaccines have been rolling out including Israel, England and Scotland — regardless of which shots are given. And the US government’s first look at real-world data among essential workers provided further evidence that the Pfizer and Moderna vaccines are highly protective -- 90% -- against infections whether there were symptoms or not.
Countries worldwide hit new records for virus cases, deaths
Nations around the world set new records Thursday for COVID-19 deaths and new coronavirus infections, and the disease surged even in some countries that have kept the virus in check. In the United States, Detroit leaders began making a plan to knock on every door to persuade people to get shots.
Brazil this week became just the third country, after the U.S. and Peru, to report a 24-hour tally of COVID-19 deaths that exceeded 4,000. India hit a peak of almost 127,000 new cases in 24 hours, and Iran set a new coronavirus infection record for the third straight day, reporting nearly 22,600 new cases.
Indian Prime Minister Narendra Modi urged people to get vaccinated, writing in a tweet: “Vaccination is among the few ways we have to defeat the virus. If you are eligible for the vaccine, get your shot soon.”
The U.S. has now fully vaccinated nearly 20% of its adult population, and New Mexico became the first state to get shots in the arms of 25% of its residents — milestones that are still far off for many hard-hit countries.
Also read: Global Covid cases top 132 million
In India, home to 1.4 billion people, only 11 million are fully vaccinated. In Brazil, less than 3% of the country’s 210 million people have received both doses, according to Our World in Data, an online research site.
South Korea reported 700 more cases, the highest daily jump since Jan. 5. Health authorities were expected to announce measures to strengthen social distancing following a meeting Friday.
In Thailand, which has reported only 95 deaths during the pandemic, health officials reported the country’s first local cases of the coronavirus variant first detected in Britain. The news comes at a time when only 1% of the population has been vaccinated and as Thais prepare to celebrate the traditional Songkran New Year’s holiday next week, typically a time of widespread travel.
That variant is more contagious, and the U.S. Centers for Disease Control and Prevention said this week that it is now the most common variant in the United States, raising concerns it will drive infections and cause more people to get sick.
Also read: Governments give varying advice on AstraZeneca vaccine
Michigan has averaged more than 7,000 new cases a day — a number that makes the state second in the nation behind New York. Michigan also has the highest number of new cases per capita, with 1 of every 203 state residents getting diagnosed with COVID-19 between March 31 and April 7, according to data compiled by Johns Hopkins University.
In Detroit, which is about 80% Black, officials said they plan to start visiting homes to talk about the importance of protecting themselves from the virus with vaccinations and how to sign up to receive the shots.
“We’re going to knock on every residential door in the city, making sure every Detroiter knows how to make an appointment,” Victoria Kovari, an executive assistant to Detroit Mayor Mike Duggan, told The Detroit News.
Only 22% of Detroit residents have received at least one vaccine dose compared to 38% for all of Michigan, according to Michigan’s Department of Health and Human Services.
Also read: COVAX reaches over 100 economies, 42 days after first international delivery
Other Midwestern states have seen troubling signs in recent days, including a school district in Iowa where 127 students and five staff members tested positive for the coronavirus or are presumed positive.
In Massachusetts, where the seven-day rolling average of daily new cases has risen to over 2,100 new cases per day, the Massachusetts Public Health Association called on Republican Gov. Charlie Baker to reinstate public health measures. The group urged Baker to limit indoor dining capacity and other indoor activities, saying the rise in cases and hospitalizations followed Baker’s decision to loosen those restrictions.
“We are currently in a race between the vaccines and the variants,” Carlene Pavlos, the group’s executive director said Thursday. “Without these public health measures, even more innocent lives will be needlessly lost.”
Governments give varying advice on AstraZeneca vaccine
In Spain, residents now have to be over 60 to get an AstraZeneca coronavirus vaccine. In Belgium, over 55. In the United Kingdom, authorities recommend the shot not be given to adults under 30 where possible, and Australia’s government announced similar limits Thursday to AstraZeneca shots for those under 50.
A patchwork of advice was emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder while reiterating the vaccine is safe and effective.
Regulators in the United Kingdom and the EU both stressed that the benefits of receiving the vaccine continue to outweigh the risks for most people, and the EU agency maintained its guidance that the vaccine can be used in all adults. But experts fear the confusing messages about the vaccine could still dampen enthusiasm for it at a time when Europe and many other parts of the world are facing surging cases.
Experts hammered home the rarity of the clots Thursday.
“The risks appear to be extremely low from this very rare side effect,” Anthony R. Cox, of the University of Birmingham’s School of Pharmacy, told the BBC. “I mean it’s the equivalent of the risk of dying in the bath, drowning in the bath, for example, it’s that rare, or a plane landing on your house.”
Also read: UK advises limiting AstraZeneca in under-30s amid clot worry
Dr. Sabine Straus, chair of the EU regulator’s Safety Committee, said the best data was from Germany, where there was one report of the clots for every 100,000 doses given, although she noted far fewer reports in the U.K. Still, that’s less than the clot risk that healthy women face from birth control pills, noted another expert, Dr. Peter Arlett. The agency said most of the cases reported were in women under 60 within two weeks of vaccination, though it was unable to identify specific risk factors based on current information.
The EU is trying, but so far failing, to avoid different policies among its 27 nations, which all look to the European Medicines Agency for guidance. Health Commissioner Stella Kyriakides called Wednesday evening for a coherent approach to ensure that “on the basis of the same set of evidence, similar decisions are taken in different member states.”
News of the tiny risk already is already having an effect. In Croatia, the government said that one in four people due to get an AstraZeneca shot Thursday didn’t show up. Poland, too, has also seen people cancel or not appear for appointments to get the vaccine.
French general practitioner Dr. Joel Valendoff said many of his patients were still coming to get their shot, but many others were canceling.
When vaccines first became available, “I was refusing people because I had a lot of demand and not enough vaccines. Today I am facing the opposite. I have vaccines but not enough volunteers.”
Also read: EU agency: Rare clots possibly linked to AstraZeneca shot
Mbaye Thiam, a 59-year-old Parisian, was among those who got vaccinated.
“I am closely monitoring the COVID-19 situation throughout the world. I am not worried. In an exceptional situation we need exceptional measures,” he said. “It is true that the vaccine was created in a record time, but the world has stopped and we need solutions to make it start again, and the vaccine is one of the solutions.”
European Commission spokesman Stefan De Keersmaecker said the EMA’s findings were based on its stringent monitoring system and that should promote trust among the bloc’s 27 member states.
“We want to avoid, of course, a vaccination hesitancy,” he said.
Any such reluctance is worrying since experts say the shots are key to stamping out the coronavirus pandemic, but AstraZeneca’s role is especially vital. The vaccine, which is cheaper and easier to store than many others, is critical to immunization campaigns in Europe and the U.K. and is also a pillar of the U.N.-backed program known as COVAX that aims to get vaccines to some of the world’s poorest countries.
John Nkengasong, the top official with the Africa Centers for Disease Control and Prevention, said his group is not issuing new recommendations and that the overarching message from the U.K. and EU regulators was clear.
Also read: UK regulator says AstraZeneca jab safe after 7 clot deaths
“The benefits outweigh the risks because these are very rare occurrences that they are picking up due to very strong surveillance systems that they have put in place,” Nkengasong told a briefing. “So, I think these vaccines continue to be safe.”
Africa’s target is to vaccinate 60% of its 1.3 billion people by the end of 2022 — a goal that could prove extremely hard to achieve without widespread use of the AstraZeneca vaccine.
Australian Prime Minister Scott Morrison, whose country’s vaccination program leans heavily on AstraZeneca’s shot, announced that the Pfizer vaccine should be adopted as the preferred vaccine for people under 50.
“We’ve been taking the necessary precautions based on the best possible medical advice,” Morrison said. “It has not been our practice to jump at shadows.”
Some EU nations were at pains to stress the safety and did not change their advice.
The Polish state TV broadcaster used a headline declaring, “AstraZeneca is safe.”
The head of Italy’s drug regulator, Nicola Magrini, appealed for calm even as she said late Wednesday that Italy will pivot from primarily using the AstraZeneca vaccine for people under 65 to using it on those over 60.
Also read: What we know about AstraZeneca blood clot reports
Underscoring how such changing rules were causing confusion and anxiety, the governor of the Veneto region said operators had fielded 8,000 calls about AstraZeneca in recent days. “Obviously there is some uneasiness spreading,” Luca Zaia told reporters.
Hungarian government minister Gergely Gulyas called the EMA announcement “a clear decision which is in line with the point of view of Hungarian authorities: AstraZeneca is reliable and provides protection.”
German officials made clear that they will stick to their current recommendation — issued March 30 when concerns about the rare clots were already circulating — to restrict the use of the AstraZeneca vaccine to people over 60 in most cases, in line with larger European nations including Spain and Italy.
In the Croatian capital, Zagreb, Josip Pavlic was among a large group of masked people who lined up for an AstraZeneca vaccination. He said he would take any shot, as infections rise sharply in the country.
“They are all the same to me. The most important is the we have vaccine, and that we can have some protection with vaccine,” he said.
COVAX reaches over 100 economies, 42 days after first international delivery
More than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the global mechanism for equitable access to COVID-19 vaccines, says the World Health Organization (WHO) on Thursday.
The milestone comes 42 days after the first COVAX doses were shipped and delivered internationally, to Ghana on 24 February 2021.
COVAX has now delivered more than 38 million doses across six continents, supplied by three manufacturers, AstraZeneca, Pfizer-BioNTech and the Serum Institute of India (SII).
Of the over 100 economies reached, 61 are among the 92 lower-income economies receiving vaccines funded through the Gavi COVAX Advance Market Commitment (AMC).
Despite reduced supply availability in March and April – the result of vaccine manufacturers scaling and optimizing their production processes in the early phase of the rollout, as well as increased demand for COVID-19 vaccines in India – COVAX expects to deliver doses to all participating economies that have requested vaccines in the first half of the year.
Also read: Covishield and Covaxin: What we know about India's Covid-19 vaccines
“In four months since the very first mass vaccination outside a clinical setting anywhere in the world, it is tremendously gratifying that the roll-out of COVAX doses has already reached one hundred countries,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.
Berkley said COVAX may be on track to deliver to all participating economies in the first half of the year yet they still face a daunting challenge as they seek to end the acute stage of the pandemic: they will only be safe when everybody is safe and our efforts to rapidly accelerate the volume of doses depend on the continued support of governments and vaccine manufacturers.
“As we continue with the largest and most rapid global vaccine rollout in history, this is no time for complacency.”
Dr Tedros Adhanom Ghebreyesus, WHO Director-General said COVAX has given the world the best way to ensure the fastest, most equitable rollout of safe and effective vaccines to all at-risk people in every country on the planet.
Also read: ‘We sink or we swim together’: 5 things you need to know about COVAX
“If we are going to realize this great opportunity, countries, producers and the international system must come together to prioritize vaccine supply through COVAX. Our collective future, literally, depends on it.”
Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) this is a significant milestone in the fight against COVID-19. “Faced with the rapid spread of COVID-19 variants, global access to vaccines is fundamentally important to reduce the prevalence of the disease, slow down viral mutation, and hasten the end of the pandemic.”
“In just a month and a half, the ambition of granting countries access to COVID vaccines is becoming a reality, thanks to the outstanding work of our partners in the COVAX Facility,” said Henrietta Fore, UNICEF Executive Director.
“However, this is no time to celebrate; it is time to accelerate. With variants emerging all over the world, we need to speed up global rollout. To do this, we need governments, along with other partners, to take necessary steps to increase supply, including by simplifying barriers to intellectual property rights, eliminating direct and indirect measures that restrict exports of COVID-19 vaccines, and donating excess vaccine doses as quickly as possible.”
Also read: WHO calls for prioritising vaccine contracts with COVAX
According to its latest supply forecast, COVAX expects to deliver at least 2 billion doses of vaccines in 2021. In order to reach this goal, the COVAX Facility will continue to diversify its portfolio further, and will announce new agreements with vaccine manufacturers in due course.
Furthermore, in March it was announced that the United States government will host the launch event for the 2021 Gavi COVAX AMC Invest Opportunity to catalyze further commitment and support for accelerated access to vaccines for AMC-supported economies.
An additional US$ 2 billion is required in 2021 to finance and secure up to a total of 1.8 billion donor-funded doses of vaccines. COVAX is also working to secure additional sourcing of vaccines in the form of dose-sharing from higher income countries.
FM calls for stronger global partnership to effectively tackle COVID-19
Foreign Minister Dr AK Abdul Momen on Wednesday called for stronger global partnership and cooperation to effectively deal with the COVID-19 pandemic.
"All countries need to work together. It's essential to have stronger partnership and cooperation among countries to face COVID-19 situation," he said as the chief guest at the 5th episode of Bangabandhu Lecture Series held virtually marking birth centenary of Father of the Nation Bangabandhu Sheikh Mujibur Rahman.
Dr Momen said people across the world need to get vaccinated to make the world free from coronavirus. "All countries need to work together to ensure equal access to vaccine," he said.
Also read: Dhaka seeks greater int'l solidarity, cooperation to tackle COVID-19 challenges
Former UN Under Secretary General Ambassador Anwarul K Chowdhury delivered keynote speech on the "Birth of Bangladesh and Its Inspirational Legacy in Global Diplomacy".
The Foreign Minister said they want to establish peace in the world in a sustainable way. Bangabandhu firmly believed that peace is a must for development and laid emphasis on peace and stability throughout his life.
"Bangabandhu and Bangladesh are inseparable," he said, noting that Bangabandhu had turned into a global leader by highlighting the problems faced by the oppressed people in the world. He said Bangabandhu ensured religious harmony in the society.
Also read: Coronavirus & Agenda 2030: Dhaka seeks meaningful global partnership
The Foreign Minister said all young diplomats need to read the speeches of Bangladesh’s founding father.
Foreign Secretary Masud Bin Momen spoke as special guest.
Diplomats stationed in Dhaka, Bangladesh envoys abroad, senior journalists and intellectuals joined the programme.